Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies
Clinical trial NCT01463982 · COMPLETED
Trial details
- NCT number
- NCT01463982
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.